Vertex Pharmaceuticals Inc (VRTX) has shown a revenue growth rate of 0.0% year-over-year. Earnings have grown by 0.0% in the same period.
Over the past 4 years, Vertex Pharmaceuticals Inc has delivered a compound annual growth rate (CAGR) of 5.0% for revenue and 2.2% for earnings.
Historical revenue and net income for Vertex Pharmaceuticals Inc
Annual percentage change in revenue and earnings
Historical EPS trends for Vertex Pharmaceuticals Inc
Earnings per share (EPS) is a key metric that shows how much profit Vertex Pharmaceuticals Inc generates for each share of stock. Over the past 4 years, EPS has grown at a CAGR of 2.4%.